Background: The southeastern coastal area of China has a high prevalence of HTLV-1
infection among blood donors. However, the estimation of HTLV-1 prevalence on a national …

Background Human T-lymphotropic virus type 1 (HTLV-1) is considered to be the etiological
agent of adult T-cell leukemia/lymphoma (ATL) and HTLV-associated myelopathy/tropical …

Background So far, the prevalence of human T-lymphotropic virus (HTLV) type 1 and 2 in
some highly populated countries such as China is still unknown. In this study, a multi-center …

BACKGROUND China has not yet incorporated routine human T‐lymphotropic virus (HTLV)‐
1/2 blood donor screening, even though HTLV has been reported in the southeastern …

Background The human T-lymphotropic virus type 1 (HTLV-1) which is associated with the
diseases of adult T-cell leukemia/lymphoma, HTLV-1 associated myelopathy/tropical spastic …

Aim: The present meta-analysis aims to assess the epidemiology of human T-lymphotropic
virus type 1 (HTLV-1) among blood donors and general population in Iran. Methods: The …

Infection with human T‐lymphotropic virus type 1/2 (HTLV‐1/2) is a major health problem.
HTLV‐1/2 infection is endemic in Chile but representative donor prevalence data are …

Objectives This study evaluated the Human T‐lymphotropic virus (HTLV) screening policy
impact on the HTLV seroprevalence from 2009 to 2018 as well as the differences between …

Background Human T-cell lymphotrophic virus type 1 (HTLV-1) has a worldwide distribution
and it is endemic in some regions of Iran. One of the most important routes of HTLV-1 …

Human T-cell lymphotropic virus type 1 (HTLV-1) infection is an endemic condition in
Northeast Iran and, as such, identification of risk factors associated with the infection in this …